Chronic subthreshold cortical stimulation for adult drug-resistant focal epilepsy: safety, feasibility, and technique

被引:24
|
作者
Kerezoudis, Panagiotis [1 ]
Grewal, Sanjeet S. [1 ]
Stead, Matthew [2 ]
Lundstrom, Brian Nils [2 ]
Britton, Jeffrey W. [2 ]
Shin, Cheolsu [2 ]
Cascino, Gregory D. [2 ]
Brinkmann, Benjamin H. [2 ]
Worrell, Gregory A. [2 ]
Van Gompel, Jamie J. [1 ]
机构
[1] Mayo Clin, Dept Neurosurg, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Neurol, Rochester, MN USA
关键词
intractable epilepsy; medically refractory epilepsy; cortical stimulation; cortical electrodes; surgical technique; TEMPORAL-LOBE EPILEPSY; INTRACTABLE PARTIAL EPILEPSY; ELECTRICAL-STIMULATION; ELOQUENT CORTEX; ONSET EPILEPSY; METAANALYSIS; ELECTRODES; TRIAL;
D O I
10.3171/2017.5.JNS163134
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Epilepsy surgery is effective for lesional epilepsy, but it can be associated with significant morbidity when seizures originate from eloquent cortex that is resected. Here, the objective was to describe chronic subthreshold cortical stimulation and evaluate its early surgical safety profile in adult patients with epilepsy originating from seizure foci in cortex that is not amenable to resection. METHODS Adult patients with focal drug-resistant epilepsy underwent intracranial electroencephalography monitoring for evaluation of resection. Those with seizure foci in eloquent cortex were not candidates for resection and were offered a short therapeutic trial of continuous subthreshold cortical stimulation via intracranial monitoring electrodes. After a successful trial, electrodes were explanted and permanent stimulation hardware was implanted. RESULTS Ten patients (6 males) who underwent chronic subthreshold cortical stimulation between 2014 and 2016 were included. Based on radiographic imaging, intracranial pathologies included cortical dysplasia (n = 3), encephalomalacia (n = 3), cortical tubers (n = 1), Rasmussen encephalitis (n = 1), and linear migrational anomaly (n = 1). The duration of intracranial monitoring ranged from 3 to 20 days. All patients experienced an uneventful postoperative course and were discharged home with a median length of stay of 10 days. No postoperative surgical complications developed (median follow-up length 7.7 months). Seizure severity and seizure frequency improved in all patients. CONCLUSIONS The authors' institutional experience with this small group shows that chronic subthreshold cortical stimulation can be safely and effectively performed in appropriately selected patients without postoperative complications. Future investigation will provide further insight to recently published results regarding mechanism and efficacy of this novel and promising intervention.
引用
收藏
页码:533 / 543
页数:11
相关论文
共 50 条
  • [31] Perampanel add-on for drug-resistant focal epilepsy
    Bresnahan, Rebecca
    Hill, Ruaraidh A.
    Wang, Jin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (04):
  • [32] Structural lesions spectrum in focal drug-resistant epilepsy
    Dragan, D.
    Iuhtimovschi, L.
    Groppa, S.
    EPILEPSIA, 2024, 65 : 95 - 96
  • [33] Potential surgical therapies for drug-resistant focal epilepsy
    Shan, Wei
    Mao, Xuewei
    Wang, Xiu
    Hogan, Robert E.
    Wang, Qun
    CNS NEUROSCIENCE & THERAPEUTICS, 2021, 27 (09) : 994 - 1011
  • [34] Oxcarbazepine add-on for drug-resistant focal epilepsy
    Bresnahan, Rebecca
    Atim-Oluk, Margaret
    Marson, Anthony G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (03):
  • [35] The Role of MRI in the Treatment of Drug-Resistant Focal Epilepsy
    Bernasconi, Andrea
    Bernasconi, Neda
    EUROPEAN NEUROLOGY, 2022, 85 (05) : 333 - 341
  • [36] Contemporary surgical management of drug-resistant focal epilepsy
    Milovanovic, Jasmina R.
    Jankovic, Slobodan M.
    Milovanovic, Dragan
    Zecevic, Dejana Ruzic
    Folic, Marko
    Kostic, Marina
    Rankovic, Goran
    Stefanovic, Srdan
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (01) : 23 - 40
  • [37] Levetiracetam add-on for drug-resistant focal epilepsy
    Mbizvo, Gashirai K.
    Chandrasekar, Bharath
    Nevitt, Sarah J.
    Dixon, Pete
    Hutton, Jane L.
    Marson, Anthony G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06):
  • [38] EFFICACY AND TOLERABILITY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN ADULT PATIENTS WITH DRUG-RESISTANT FOCAL EPILEPSY
    Vignoli, A.
    Chiesa, V
    La Briola, F.
    Gardella, E.
    Zambrelli, E.
    Canevini, M. P.
    EPILEPSIA, 2011, 52 : 111 - 112
  • [39] Resective epilepsy surgery in a 55-year-old man with focal cortical dysplasia and drug-resistant epilepsy
    Yue, Jiong
    Zhang, Guanni
    Zhao, Dongdong
    LANCET, 2023, 402 (10414): : 1786 - 1787
  • [40] Technical note: preliminary surgical experience with a new implantable epicranial stimulation device for chronic focal cortex stimulation in drug-resistant epilepsy
    Coenen, Volker A.
    Jarc, Nadja
    Hirsch, Martin
    Reinacher, Peter C.
    Steinhoff, Bernhard J.
    Bast, Thomas
    Schulze-Bonhage, Andreas
    Sajonz, Bastian E. A.
    ACTA NEUROCHIRURGICA, 2024, 166 (01)